These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30787364)

  • 1. Genetic characterization of thymoma.
    Yu L; Ke J; Du X; Yu Z; Gao D
    Sci Rep; 2019 Feb; 9(1):2369. PubMed ID: 30787364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
    Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
    Front Immunol; 2020; 11():664. PubMed ID: 32373124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of Gene Variation in Thymoma by Microarray].
    Wang L; Yu L; Du X; Huo C
    Zhongguo Fei Ai Za Zhi; 2020 Dec; 23(12):1073-1079. PubMed ID: 33357314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alteration in gene expression profile of thymomas with or without myasthenia gravis linked with the nuclear factor-kappaB/autoimmune regulator pathway to myasthenia gravis pathogenesis.
    Guo F; Wang CY; Wang S; Zhang J; Yan YJ; Guan ZY; Meng FJ
    Thorac Cancer; 2019 Mar; 10(3):564-570. PubMed ID: 30734484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of CD20 in thymomas and its clinical implication].
    Du J; Zhou XJ; Yin HL; Lu ZF; Zhou HB
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):611-4. PubMed ID: 21092589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of DNMT3a expression by RNAi and its effect on NF-κBs expression of thymic epithelial cells.
    Meng FJ; Guo F; Sun ZN; Wang SJ; Yang CR; Wang CY; Zhang WC; Gao ZY; Ji LL; Feng FK; Guan ZY; Wang GS
    Immunol Lett; 2021 Sep; 237():17-26. PubMed ID: 34192561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of
    Masunaga A; Omatsu M; Kunimura T; Uematsu S; Kamio Y; Kitami A; Miyagi Y; Hiroshima K; Suzuki T
    J Clin Pathol; 2017 Aug; 70(8):690-696. PubMed ID: 28119349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes.
    Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H
    BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Histologic subtyping and prognosis of thymoma: a study of 108 cases].
    Jiao X; Yin HL; Lu ZF; Zhao YC; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2008 Jul; 37(7):445-9. PubMed ID: 19035114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different characteristics of thymomas with and without myasthenia gravis.
    Yu L; Zhang XJ; Ma S; Jing Y; Li F; Krasna MJ
    Ann Surg Oncol; 2012 Jan; 19(1):94-8. PubMed ID: 21879277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The relationship between myasthenia gravis and the different pathological type of thymoma patients' operation and prognosis].
    Zhang Y; Yu L; Jing Y; Ke J
    Zhonghua Wai Ke Za Zhi; 2015 Aug; 53(8):612-6. PubMed ID: 26653963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The level of Bcl-2 and Fas expression in thymoma tissue from patients with myasthenia gravis].
    Shen G; Chai Y; Yue L; Wei HQ; Lin M
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Apr; 29(4):240-2. PubMed ID: 16750039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial autoimmune myasthenia gravis and thymoma: occurrence in two brothers.
    Pascuzzi RM; Sermas A; Phillips LH; Johns TR
    Neurology; 1986 Mar; 36(3):423-7. PubMed ID: 3951715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two types of immune infiltrating cells and six hub genes can predict the occurrence of myasthenia gravis in patients with thymoma.
    Tao Z; Lu C; Gao S; Zhang P; Chen Y; Wang Y; Yang Z; Xiong K; Liu Y; Zhang P
    Bioengineered; 2021 Dec; 12(1):5004-5016. PubMed ID: 34620045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA and mRNA expression associated with myasthenia gravis in patients with thymoma.
    Ke J; Du X; Cui J; Yu L; Li H
    Thorac Cancer; 2022 Jan; 13(1):15-23. PubMed ID: 34773374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of HLA-A in autoimmune myasthenia gravis with thymoma.
    Vandiedonck C; Raffoux C; Eymard B; Tranchant C; Dulmet E; Krumeich S; Gajdos P; Garchon HJ
    J Neuroimmunol; 2009 May; 210(1-2):120-3. PubMed ID: 19278738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different molecular expression in thymoma with ocular or generalized myasthenia gravis.
    Zhang M; Li H; Guo J; Zhou Y; Gong L; Wang X; Li Z; Zhang W
    J Neurol Sci; 2012 Feb; 313(1-2):27-31. PubMed ID: 22000402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
    Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
    Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infrequent and low AIRE expression in thymoma: difference in AIRE expression among WHO subtypes does not correlate with association of MG.
    Suzuki E; Kobayashi Y; Yano M; Fujii Y
    Autoimmunity; 2008 Aug; 41(5):377-82. PubMed ID: 18568643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corpuscular thymoma: entity or variant of organotypical thymomas WHO B2/B3?
    Laeng RH; Eimoto T; Kuo TT; Zettl A; Marx A; Moschopulos M; Tateyama H; Shimokawa K
    Pathol Res Pract; 2006; 202(10):697-704. PubMed ID: 16887284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.